NVNO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 13:46):

Stats
Today's Volume	60 038.00
Average Volume	134 059
Market Cap	68.52M
EPS	$0 ( 2024-02-29 )
Next earnings date	( $-0.400 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.69
ATR14	$0.0380 (0.74%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-13	Alavi Hamed	Sell	8 334	Stock Options
2024-03-13	Alavi Hamed	Buy	8 334	Common Stock
2024-03-13	Alavi Hamed	Sell	8 334	Common Stock
2023-12-05	Glynn Craig	Buy	75 000	Stock Options
2023-12-05	Jenusaitis Matthew	Buy	13 856	Stock Options

INSIDER POWER
43.57
Last 98 transactions
Buy: 6 344 915 \| Sell: 2 475 147

Volume Correlation

Long: 0.02 (neutral)

Short: 0.72 (moderate)

Signal:(57.534) Neutral

enVVeno Medical Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

enVVeno Medical Correlation - Currency/Commodity

0.39
( neutral )

0.04
( neutral )

0.00
( neutral )

-0.20
( neutral )

-0.02
( neutral )

-0.42
( neutral )

enVVeno Medical Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-546 000 (0.00 %)
EPS:	$-1.910

Q4	2023
Revenue:	$824 000
Gross Profit:	$690 000 (83.74 %)
EPS:	$-0.420

Q3	2023
Revenue:	$0
Gross Profit:	$-138 000 (0.00 %)
EPS:	$-0.450

Q2	2023
Revenue:	$0
Gross Profit:	$-138 000 (0.00 %)
EPS:	$-0.580

Financial Reports:

No articles found.

enVVeno Medical

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.